Eidos Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eidos Therapeutics, Inc.
CIK #0001731831
EDGAR Form CIK 2011 - 2025
10-K [0001731831]
10-Q [0001731831]
3 [0001731831]
4 [0001731831]
5 [0001731831]
8-K [0001731831]
D [0001731831]
SC 13D [0001731831]
SC 13G [0001731831]
Form 13D/13G Filer Form 13D/13G Subject Filed
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
Bridgebio Pharma LLC Eidos Therapeutics Inc [2018-08-01]
Viking Global Investors LP Eidos Therapeutics Inc [2018-07-02]
RA Capital Management LLC Eidos Therapeutics Inc [2018-07-02]
Form 3/4/5 Subject 2011 - 2025
Sinha Uma
Eidos Therapeutics, Inc.
Fox Jonathan C
Rohlen Douglas
Valle Franco
Turtle Cameron
Satvat Ali J.
Lis William
Hooper Suzanne Sawochka
BridgeBio Pharma, Inc.
View All
Terms | Privacy | Guide
tony@aum13f.com